Hypophosphatemia
Conditions
Brief summary
The aim of this study is to generate evidence regarding hypophosphatemia after iron infusion in lung transplant recipients in context of anemia and/or iron deficiency.
Interventions
OTHERno intervention
no intervention
Sponsors
University of Zurich
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* lung transplant recipient * treated at the University Hospital Zurich between 2015 until 2022
Exclusion criteria
* Denied general consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of serum phosphate level | Baseline and up to 90 days after iron infusion | Change of serum phosphate level before and after iron infusion |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change of hemoglobin | Baseline and up to 90 days after iron infusion | Change of hemoglobin level before and after iron infusion |
| Change of mean corpuscular volume (MCV) | Baseline and up to 90 days after iron infusion | Changes of serum MCV level before and after iron infusion |
| Change of mean corpuscular hemoglobin (MCH) | Baseline and up to 90 days after iron infusion | Change of serum MCH level before and after iron infusion |
| Change of serum magnesium | Baseline and up to 90 days after iron infusion | Change of serum magnesium level before and after iron infusion |
| Change of urin phosphate level | Baseline and up to 90 days after iron infusion | Change of urin phosphate level before and after iron infusion |
| Change of serum albumin | Baseline and up to 90 days after iron infusion | Change of serum albumin level before and after iron infusion |
| Complications after iron infusion | 2015-2022 | Number of patients with complications due to hypophosphatemia after iron infusion (Hospitalization, hypoxia, fracture due to hypophosphatemia) |
| Predictors | baseline and up to 90 days after iron infusion | Analysis of possible predictors for the decrease of serum phosphate levels after iron infusion |
| Therapeutic management | 2015 to 2022 | Descriptive analysis of therapeutic management of hypophosphatemia after iron infusion |
| Change of serum and urin calcium | Baseline and up to 90 days after iron infusion | Change of serum and urin calcium level before and after iron infusion |
Countries
Switzerland
Outcome results
None listed